Maxalt (Rizatriptan Benzoate) - Summary

MAXALT SUMMARY

What is MAXALT and what is it used for?

MAXALT contains rizatriptan benzoate, a selective 5-hydroxytryptamine_1B/1D(5-HT_1B/1D) receptor agonist.

MAXALT is indicated for the acute treatment of migraine attacks with or without aura in adults.

MAXALT is not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine (see CONTRAINDICATIONS). Safety and effectiveness of MAXALT have not been established for cluster headache, which is present in an older, predominantly male population.

MAXALT NEWS HIGHLIGHTS

Media Articles Related to Maxalt (Rizatriptan)

Migraines More Frequent, Intense in Overweight Kids
Source: MedicineNet Headache Specialty [2008.09.29]

Migraine Research Foundation Announces Winners Of Grants To Spur Innovation In Migraine Research
Source: Headache / Migraine News From Medical News Today [2008.09.22]

Migraine Linked To Blood Clots In Veins
Source: Headache / Migraine News From Medical News Today [2008.09.17]

Migraines Linked to Vein Blood Clots
Source: MedicineNet Deep Vein Thrombosis Specialty [2008.09.16]

Oral CGRP Receptor Antagonist Showed Statistically Significant Improvement In Migraine Relief Versus Placebo
Source: Headache / Migraine News From Medical News Today [2008.09.08]

more>>

Published Studies Related to Maxalt (Rizatriptan)

Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment. [2008.06]

Effects of rizatriptan on the contingent negative variation in healthy women. [2008.05.28]

Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial. [2008.03]

Elimination of Migraine-Associated Nausea in Patients Treated with Rizatriptan Orally Disintegrating Tablet (ODT): A Randomized, Double-Blind, Placebo-Controlled Study. [2007.11.28]

A randomized trial of rizatriptan in migraine attacks in children. [2006.10.10]

more>>

Clinical Trials Related to Maxalt (Rizatriptan)

Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache [Active, not recruiting]

Two Rizatriptan Prescribing Portions for Treatment of Migraine [Completed]

Study to Test a Marketed Drug (MK0462) in the Early Treatment of Acute Migraine [Active, not recruiting]

Drug Study in Pediatric Subjects With Migraines [Active, not recruiting]

The Effects of Expectation and Knowledge on Rizatriptan and Placebo Treatment of Acute Migraine Headache [Not yet recruiting]

more>>